Difficulty: Medium
Average Score: 91%
Practice
For a patient who is receiving chemotherapy, which laboratory result is of particular importance?
Correct answer
A
Rationale
In a patient receiving chemotherapy, the laboratory result of particular importance is the white blood cell (WBC) count (Option A). Chemotherapy can suppress the bone marrow's ability to produce WBCs, leading to a condition called neutropenia, which increases the risk of infections. Monitoring the WBC count helps healthcare providers assess the patient's immune function and determine if any interventions, such as administering growth factors or adjusting the chemotherapy regimen, are necessary to prevent or manage infections.
Option B, PT and PTT, are coagulation studies that assess the clotting function of the blood and are not directly related to the immune system or infection risk in a patient receiving chemotherapy.
Option C, electrolytes, are important for assessing hydration status and metabolic function but are not specifically indicative of the immune status in a patient undergoing chemotherapy.
Option D, BUN (blood urea nitrogen), is a marker of kidney function and hydration status but does not directly reflect the immune function in a patient on chemotherapy.
Understanding the significance of monitoring the WBC count in chemotherapy patients is crucial for healthcare professionals to provide safe and effective care. Regular monitoring and appropriate management based on these results can help prevent serious complications and improve patient outcomes during cancer treatment.
Option B, PT and PTT, are coagulation studies that assess the clotting function of the blood and are not directly related to the immune system or infection risk in a patient receiving chemotherapy.
Option C, electrolytes, are important for assessing hydration status and metabolic function but are not specifically indicative of the immune status in a patient undergoing chemotherapy.
Option D, BUN (blood urea nitrogen), is a marker of kidney function and hydration status but does not directly reflect the immune function in a patient on chemotherapy.
Understanding the significance of monitoring the WBC count in chemotherapy patients is crucial for healthcare professionals to provide safe and effective care. Regular monitoring and appropriate management based on these results can help prevent serious complications and improve patient outcomes during cancer treatment.